NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Acute Impact of the Impella CP Assist Device in Pts. With Cardiogenic Shock on the Patients Hemodynamic

CompletedNA

Sponsor: University of Leipzig

Conditions: Cardiogenic Shock

Interventions: Impella CP microaxial pump

Countries: Germany

Prospective, monocentric open-label observational study for the assessment of acute hemodynamic effects following implantation of the IMPELLA CP cardiac support device

Eligibility overview

Sex: ALL

Age: 16 Years to 91 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Cardiogenic shock following acute MI or acute heart failure with

  * systolic BP \< 90 mm Hg over \> 30 min or inotropes for support of cardiac output and BP with
  * signs of left heart failure and pulmonary congestion
  * and end-organ hypo perfusion with somnolence or cold, pale skin, or oliguria or serum lactate \>2 mmol/l

Exclusion Criteria:

Locations (1)

Jena, Germany